Common Stock Purchase Warrant Sample Contracts

Reign Sapphire Corp – Common Stock Purchase Warrant Reign Sapphire Corporation (February 23rd, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the funding of the $147,000.00 convertible promissory note issued to the Holder (as defined below) of even date) (the "Note"), _____________________, a ___________________________ (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Reign Sapphire Corporation, a Delaware corporation (the "Company"), 980,000 shares of Common Stock (as defined below) (the "Warrant Shares") at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated February 16, 2018, by and among the Company and the Holder (the "Purchase Agreement").

Tetridyn Solutions Inc – Common Stock Purchase Warrant Ocean Thermal Energy Corporation (February 23rd, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the funding of the purchase price of $100,000.00, with respect to the first tranche of $121,111.000 issuance of that certain senior secured promissory note in the original principal amount of $565,555.00 on February 16, 2018 by the Company (as defined below) to the Holder (as defined below)) (the "Note"), L2 Capital, LLC, a Kansas limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Ocean Thermal Energy Corporation, a Nevada corporation (the "Company"), up to 242,222 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) (with the understanding that

Tetridyn Solutions Inc – Common Stock Purchase Warrant Ocean Thermal Energy Corporation (February 23rd, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received in connection with the Agreement (as defined below), the Holder (as defined below), Craft Capital Management, LLC (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Ocean Thermal Energy Corporation, a Nevada corporation (the "Company"), up to 12,000 shares of Common Stock (as defined below) (the "Warrant Shares") at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain agreement between the Holder and the Company dated June 26, 2017 (the "Agreement"), as a result of the issuance of that certain promissory note under the securities purchase agreement between the Company and L2 Capital, LLC (the "Holder'), entered into by the Com

HPC Acquisitions, Inc. – COMMON STOCK PURCHASE WARRANT to Purchase 800,000 Shares of Common Stock Of (February 22nd, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") CERTIFIES that, for value received, Ryan Sweeney (the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or prior to January 31, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Vegalab, Inc., a Nevada corporation (the "Company"), up to 800,000 shares (the "Warrant Shares") of Common Stock, par value $0.001 per share, of the Company (the "Common Stock"). The purchase price of one share of Common Stock (the "Exercise Price") under this Warrant shall be $1.20. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.

HPC Acquisitions, Inc. – COMMON STOCK PURCHASE WARRANT to Purchase 800,000 Shares of Common Stock Of (February 22nd, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") CERTIFIES that, for value received, Jeffry Hill (the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or prior to January 31, 2023 (the "Termination Date") but not thereafter, to subscribe for and purchase from Vegalab, Inc., a Nevada corporation (the "Company"), up to 800,000 shares (the "Warrant Shares") of Common Stock, par value $0.001 per share, of the Company (the "Common Stock"). The purchase price of one share of Common Stock (the "Exercise Price") under this Warrant shall be $1.20. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.

Brooklyn Cheesecake & Dessrt – SERIES a COMMON STOCK PURCHASE WARRANT Meridian Waste Solutions, Inc. (February 22nd, 2018)

THIS SERIES A COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the earlier of (i) the date Shareholder Approval is obtained and deemed effective and (ii) _____, 20181 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on _________2 (the "Termination Date") but not thereafter, to subscribe for and purchase from Meridian Waste Solutions, Inc., a New York corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares", and such aggregate number of Warrant Shares issuable hereunder, as subject to adjustment hereunder, the "Warrant Number") of Common Stock; provided, however, that only up to ________ Warrant Shares (as subject to adjustment hereunder) may be initially issued on exercise(s) of this Warrant. The

Sysorex Global Holdings Corp. – COMMON STOCK PURCHASE WARRANT Inpixon (February 16th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Inpixon, a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Moleculin Biotech, Inc. – COMMON STOCK PURCHASE WARRANT Moleculin Biotech, Inc. (February 16th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August ___, 20181 (the "Initial Exercise Date") and on or prior to 5:00 p.m. (New York City time) on August ___, 20232 (the "Termination Date") but not thereafter, to subscribe for and purchase from Moleculin Biotech, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Actinium Pharmaceuticals, Inc. – Series a Common Stock Purchase Warrant (February 15th, 2018)

THIS SERIES A COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Cede & Co. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March [ ], 2018 (the "Initial Exercise Date") and on or prior to the close of business on the one (1) year anniversary of the Initial Exercise Date (the "Termination Date"); provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from Actinium Pharmaceuticals, Inc., a Delaware corporation (the "Company"), up to [_______] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form

Actinium Pharmaceuticals, Inc. – Series B Common Stock Purchase Warrant (February 15th, 2018)

THIS SERIES B COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, Cede & Co. or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after March [ ], 2018 (the "Initial Exercise Date") and on or prior to the close of business on the thirty (30) month anniversary of the Initial Exercise Date (the "Termination Date"); provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day) but not thereafter, to subscribe for and purchase from Actinium Pharmaceuticals, Inc., a Delaware corporation (the "Company"), up to [_______] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the

Sysorex Global Holdings Corp. – COMMON STOCK PURCHASE WARRANT Inpixon (February 7th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Inpixon, a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Onconova Therapeutics Inc. – Pre-Funded Common Stock Purchase Warrant Onconova Therapeutics, Inc. (February 7th, 2018)

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (this Warrant) certifies that, for value received, or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the Initial Exercise Date) until this Warrant is exercised in full (the Termination Date), but not thereafter, to subscribe for and purchase from Onconova Therapeutics, Inc., a Delaware corporation (the Company), up to shares of Common Stock (as subject to adjustment hereunder, the Warrant Shares). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Ophthalix Inc – COMMON STOCK PURCHASE WARRANT to Purchase [________] Shares of Common Stock of WIZE PHARMA, INC. (February 6th, 2018)

THIS COMMON STOCKPURCHASE WARRANT (this "Warrant") CERTIFIES that, for value received, [___________________] (the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or from time to time on or after the date of issuance of this Warrant (such date, the "Initial Exercise Date") and on or prior to 5:00 p.m., New York time, on November 16, 2020 (the "Expiration Date") but not thereafter, to subscribe for and purchase from Wize Pharma, Inc., a Delaware corporation (the "Company"), up to [___________] (the "Warrant Shares") shares of Common Stock, par value $ 0.001 per share, of the Company (the "Common Stock"). The purchase price of one Warrant Share (the "Exercise Price") under this Warrant shall be $0.082, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.

Telik, Inc. – Form of Common Stock Purchase Warrant Mabvax Therapeutics Holdings, Inc. (February 6th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [ ] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six month anniversary of the Initial Issuance Date (the "Initial Exercise Date") and on or prior to the close of business on the thirty six (36) month anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from MABVAX THERAPEUTICS HOLDINGS, INC., a Delaware corporation (the "Company"), up to [ ] shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Amendment to Common Stock Purchase Warrant (February 5th, 2018)

This Amendment to Common Stock Purchase Warrant (this "Amendment") is entered into as of February 2, 2018, by and between CareView Communications, Inc., a Nevada corporation (the "Company") and Rockwell Holdings I, LLC, a Wisconsin limited liability company (the "Holder").

Common Stock Purchase Warrant Nanoflex Power Corporation (February 5th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the funding of purchase price of $58,500.00, for the first tranche of $65,000.00 under the $130,000.00 convertible promissory note issued to the Holder (as defined below) on January 23, 2018) (the "Note"), Crown Bridge Partners, LLC (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Nanoflex Power Corporation, a Florida corporation (the "Company"), 97,500 shares of Common Stock (as defined below) (the "Warrant Shares") at the Exercise Price per share then in effect (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant).

Medizone International Inc – Common Stock Purchase Warrant Medizone International, Inc. (February 5th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the issuance of the $152,500.00 convertible promissory note to the Holder (as defined below) of even date) (the "Note"), L2 Capital, LLC, a Kansas limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Medizone International, Inc., a Nevada corporation (the "Company"), up to 2,833,168 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated January 31, 2018, by and among the Comp

Medizone International Inc – Common Stock Purchase Warrant Medizone International, Inc. (February 5th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the issuance of the $152,500.00 convertible promissory note to the Holder (as defined below) of even date) (the "Note"), SBI Investments LLC, 2014-1, a statutory series of Delaware limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Medizone International, Inc., a Nevada corporation (the "Company"), up to 2,833,168 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated Januar

Common Stock Purchase Warrant Opgen, Inc. (February 2nd, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 PM New York City time on February 6, 2023, (the "Termination Date") but not thereafter, to subscribe for and purchase from OpGen, Inc., a Delaware corporation (the "Company"), up to ______ shares of common stock, par value $0.01 per share (the "Common Stock") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Pre-Funded Common Stock Purchase Warrant Opgen, Inc. (February 2nd, 2018)

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT` (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date") but not thereafter, to subscribe for and purchase from OpGen, Inc., a Delaware corporation (the "Company"), up to ______ shares of common stock, par value $0.01 per share (the "Common Stock") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Monster Digital, Inc. – COMMON STOCK PURCHASE WARRANT INNOVATE BIOPHARMACEUTICALS, Inc. (February 2nd, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date"), provided that, if such date is not a Trading Day, the Termination Date should be the immediately following Trading Day, but not thereafter, to subscribe for and purchase from Innovate Biopharmaceuticals, Inc., a Delaware corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

AMEDICA Corp – Common Stock Purchase Warrant Amedica Corporation (February 1st, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the funding of the purchase price of $500,000.00, with respect to the first tranche of $565,000.00 under that certain convertible promissory note in the original principal amount of $840,000.00 on January 30, 2018 by the Company (as defined below) to the Holder (as defined below)) (the "Note"), L2 Capital, LLC, a Kansas limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Amedica Corporation, a Delaware corporation (the "Company"), up to 68,257 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) (with the understanding that the Holder shall only

Knight Knox Development Corp. – Artelo Biosciences, Inc. Series B Common Stock Purchase Warrant (February 1st, 2018)

This Series B Common Stock Purchase Warrant (this "Warrant") is issued pursuant to the Subscription Agreement between the Holder and the Company (the "Subscription Agreement"). Capitalized terms used herein, but not otherwise defined, shall have the meanings ascribed to such terms in the Subscription Agreement.

Sysorex Global Holdings Corp. – COMMON STOCK PURCHASE WARRANT Inpixon (February 1st, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Inpixon, a Nevada corporation (the "Company"), up to ______ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Common Stock Purchase Warrant Opgen, Inc. (January 31st, 2018)

THIS COMMON STOCK PURCHASE WARRANT` (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 PM New York City time on [FIVE YEAR ANNIVERSARY OF THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT], or if the final day of such period falls on a date that is not a Trading Day, the next succeeding Trading Day (the "Termination Date") but not thereafter, to subscribe for and purchase from OpGen, Inc., a Delaware corporation (the "Company"), up to ______ shares of common stock, par value $0.01 per share (the "Common Stock") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to th

Common Stock Purchase Warrant Opgen, Inc. (January 31st, 2018)

THIS COMMON STOCK PURCHASE WARRANT` (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to 5:00 PM New York City time on ____, 2023, or if the final day of such period falls on a date that is not a Trading Day, the next succeeding Trading Day (the "Termination Date") but not thereafter, to subscribe for and purchase from OpGen, Inc., a Delaware corporation (the "Company"), up to ______ shares of common stock, par value $0.01 per share (the "Common Stock") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Common Stock Purchase Warrant (January 31st, 2018)

This warrant to purchase Common Stock ("Warrant") is issued in connection with and pursuant to that certain Credit Agreement dated as of January 25, 2018 (the "Credit Agreement"), by and between the Company and Holder.

Cytodyn Inc – Common Stock Purchase Warrant Cytodyn Inc. (January 31st, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the Warrant) certifies that, for value received, [ ] or its assigns (the Holder) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [ ] (the Initial Exercise Date) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the Termination Date) but not thereafter, to subscribe for and purchase from CytoDyn Inc., a Delaware corporation (the Company), up to [ ] shares (as subject to adjustment hereunder, the Warrant Shares) of common stock, par value $0.001 per share (the Common Stock) of the Company. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Pre-Funded Common Stock Purchase Warrant Opgen, Inc. (January 31st, 2018)

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT` (the "Warrant") certifies that, for value received, _____________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") until this Warrant is exercised in full (the "Termination Date") but not thereafter, to subscribe for and purchase from OpGen, Inc., a Delaware corporation (the "Company"), up to ______ shares of common stock, par value $0.01 per share (the "Common Stock") (as subject to adjustment hereunder, the "Warrant Shares"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Hancock Jaffe Laboratories, Inc. – COMMON STOCK PURCHASE WARRANT Hancock Jaffe Laboratories, Inc. (January 26th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received [*] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated as of January [__], 2018, by and among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the "Company") and the Holders signatory thereto, as amended, modified or supplemented from time to time in accordance with its terms (the "Purchase Agreement"), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth (5th) anniversary of the Original Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from the Company, subject to adjustment as set forth in Section 2.2 (a)(iii) of the Purchase Agreement, up to a number of shares of the Company's common stock, par value $0.00001 per share (the "Common Stock") equal to fifty percent (50%)

Bbooth, Inc. – Common Stock Purchase Warrant Nfusz, Inc. (January 26th, 2018)

This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the issuance of the $75,000.00 convertible promissory note to the Holder (as defined below) of even date) (the "Note"), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from nFusz, Inc., a Nevada corporation (the "Company"), up to 500,000 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated January 10, 2018, by and among the Company and the Holder

Common Stock Purchase Warrant Vuzix Corporation (January 26th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _______________________ or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January [ ], 2018 (the "Initial Exercise Date") and on or prior to the close of business on the one year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Vuzix Corporation, a Delaware corporation (the "Company"), up to ____________ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

Hancock Jaffe Laboratories, Inc. – Amended and Restated Common Stock Purchase Warrant Hancock Jaffe Laboratories, Inc (January 26th, 2018)

THIS AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received [ ] or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth and in the Securities Purchase Agreement, dated June 15, 2017, as amended, among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the "Company") and the investors party thereto (the "Purchase Agreement"), at any time on or after the Original Issue Date and on or prior to the close of business on the fifth anniversary of the Original Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from the Company, up to a number of shares of the Company's common stock, par value $0.00001 per share, (the "Common Stock") equal to seventy-five percent (75%) of the number of shares of Common Stock issued upon conversion of the Holder's Note at the applicable Conversion Price under the Note (as subject to adjustm

Bbooth, Inc. – Common Stock Purchase Warrant Nfusz, Inc. (January 26th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, EMA Financial, LLC, a Delaware limited liability company (the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (as defined above) and on or prior to the close of business on the fifth (5th) anniversary of the Issue Date (the "Termination Date") but not thereafter, to subscribe for and purchase from NFUSZ, INC., a Nevada corporation (the "Company"), up to 500,000 shares (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b), subject to adjustment herein. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agr

Sew Cal Logo Inc – Common Stock Purchase Warrant Social Life Network, Inc. (January 25th, 2018)

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, [Name of Investor], or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [Exercise Date] (the "Initial Exercise Date") and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Social Life Network, Inc., a Nevada corporation (the "Company"), up to [Shares Number] ( [Shares Written] Thousand ) shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).